N
Nicolas Morin
Researcher at Merck & Co.
Publications - 6
Citations - 334
Nicolas Morin is an academic researcher from Merck & Co.. The author has contributed to research in topics: White adipose tissue & Receptor. The author has an hindex of 6, co-authored 6 publications receiving 295 citations.
Papers
More filters
Journal ArticleDOI
The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation
Yaël Mamane,Chi-Chung Chan,Genevieve Lavallee,Nicolas Morin,Lijing Xu,JingQi Huang,R. Gordon,Winston Thomas,John Lamb,Eric E. Schadt,Brian P. Kennedy,Joseph A. Mancini +11 more
TL;DR: The results suggest that the C3aR in macrophages, and potentially adipocytes, plays an important role in adipose tissue homeostasis and insulin resistance.
Journal ArticleDOI
Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores.
Marcella Funicello,Michela Novelli,Maurizio Ragni,Teresa Vottari,Cesare Cocuzza,Joaquin Soriano-Lopez,Chiara Chiellini,Federico Boschi,Pasquina Marzola,Pellegrino Masiello,Paul Saftig,Ferruccio Santini,René St-Jacques,Sylvie Desmarais,Nicolas Morin,Joseph A. Mancini,M. David Percival,Aldo Pinchera,Margherita Maffei +18 more
TL;DR: It is demonstrated that under a HFD, ctsk deficiency confers a partial resistance to the development of dyslipidemia and ctsK ablation in mice results in reduced body fat content under conditions requiring a rapid accumulation of fat stores.
Journal ArticleDOI
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.
Jacques Yves Gauthier,Michel Belley,Denis Deschenes,Jean-François Fournier,Sébastien Gagné,Yves Gareau,Martine Hamel,Martin Henault,Huda Hyjazie,Stacia Kargman,Genevieve Lavallee,Jean-François Lévesque,Lianhai Li,Yaël Mamane,Joseph A. Mancini,Nicolas Morin,Erin F. Mulrooney,Joel Robichaud,Michel Therien,Geoffrey K. Tranmer,Zhaoyin Wang,Jin Wu,W. Cameron Black +22 more
TL;DR: A weak, UDP-competitive antagonist of the pyrimidinergic receptor P2RY(14) with a naphthoic acid core was identified through high-throughput screening and optimization provided compounds with improved potency but poor pharmacokinetics.
Journal ArticleDOI
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14
Joel Robichaud,Jean-François Fournier,Sébastien Gagné,Jacques Yves Gauthier,Martine Hamel,Yongxin Han,Martin Henault,Stacia Kargman,Jean-François Lévesque,Yaël Mamane,Joseph A. Mancini,Nicolas Morin,Erin F. Mulrooney,Jin Wu,W. Cameron Black +14 more
TL;DR: The series of competitive antagonists against the G-protein coupled receptor P2Y(14) were found to be highly shifted in the presence of serum and led to the identification of the zwitterion 2, which is substantially less shifted than the previous lead compound 1.
Journal ArticleDOI
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.
Daniel Guay,Christian Beaulieu,Michel Belley,Sheldon Crane,Jeancarlo DeLuca,Yves Gareau,Martine Hamel,Martin Henault,Huda Hyjazie,Stacia Kargman,Chi-Chung Chan,Lijing Xu,Robert Gordon,Lianhai Li,Yaël Mamane,Nicolas Morin,Joseph A. Mancini,Michel Therien,Geoffrey K. Tranmer,Vouy Linh Truong,Zhaoyin Wang,W. Cameron Black +21 more
TL;DR: Compound 18q was identified as a 10 nM P2Y(14) antagonist with good oral bioavailability and provided sufficient exposure in mice to be used as a tool for future in vivo studies.